Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$4.91 -0.12 (-2.39%)
At close: Sep 30, 2026 · 4:00 PM EDT

Vanda Pharmaceuticals (VNDA) Operating Expenses (2010 - 2026)

Updated

Vanda Pharmaceuticals (VNDA) posted Operating Expenses of $114.34 million for Q2 2026, up 25.5% from $91.09 million a year earlier and up 12.2% from the prior quarter.

Analysis

Vanda Pharmaceuticals (VNDA) Operating Expenses (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Vanda Pharmaceuticals was $401.39 million, up 31.9% year-over-year; for FY2025, it came in at $367.27 million, up 53.4% from FY2024.

  • Annual Operating Expenses shows a five-year compound annual growth rate of 10.7% (FY2020 to FY2025).
  • In prior years, Vanda Pharmaceuticals' Operating Expenses was $239.43 million in FY2024 (+15.9%), $206.59 million in FY2023 (-16.7%), $248.05 million in FY2022 (+9.5%) and $226.52 million in FY2021 (+2.5%).
  • The Q2 2026 figure stands as the highest quarterly Operating Expenses in data going back to Q2 2010.
  • On a year-over-year basis, Operating Expenses has increased in each of the last nine quarters, with growth averaging 37.9% over the last eight quarters.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q1 2025, with growth of 60.6%; the weakest was Q3 2023, with a decline of 27.0%.
  • According to Business Quant data, Operating Expenses for the three prior quarters was $101.94 million (Q1 2026), $97.57 million (Q4 2025) and $87.54 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Vanda Pharmaceuticals 296.83 Mn -633.11 Mn 46.97 Mn 114.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 114.34 Mn
Mar 31, 2026 101.94 Mn
Dec 31, 2025 97.57 Mn
Sep 30, 2025 87.54 Mn
Jun 30, 2025 91.09 Mn
Mar 31, 2025 91.07 Mn
Dec 31, 2024 63.46 Mn
Sep 30, 2024 58.65 Mn
Jun 30, 2024 60.62 Mn
Mar 31, 2024 56.70 Mn
Dec 31, 2023 52.37 Mn
Sep 30, 2023 44.81 Mn
Jun 30, 2023 48.92 Mn
Mar 31, 2023 60.49 Mn
Dec 31, 2022 57.85 Mn
Sep 30, 2022 61.41 Mn
Jun 30, 2022 60.93 Mn
Mar 31, 2022 67.86 Mn
Dec 31, 2021 59.38 Mn
Sep 30, 2021 59.28 Mn
API Access

Vanda Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=VNDA&period=max&api_key=YOUR_API_KEY